<!DOCTYPE html>
<html lang="en">
  <head>
  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">

  <title>New breakthroughs</title>
  <meta property="og:title" content="New breakthroughs" />
  <meta name="twitter:title" content="New breakthroughs" />
  <meta name="description" content="&nbsp;&nbsp;&nbsp; &nbsp;A team of Chinese, Japanese and Korean researchers led by Professor Xu Ruihua of Sun Yat-sen University&rsquo;s Cancer Hospital conducted a large-scale, multi-center, phase III clinical trial of patients with advanced colorectal cancer after failed first-line treatment, AXEPT Research (Study No. NCT01996306) Objective To investigate the efficacy and tolerance of the modified double-drug combination scheme ( capecitabine&#43; irinotecan, XELIRI for short).

">
  <meta property="og:description" content="&nbsp;&nbsp;&nbsp; &nbsp;A team of Chinese, Japanese and Korean researchers led by Professor Xu Ruihua of Sun Yat-sen University&rsquo;s Cancer Hospital conducted a large-scale, multi-center, phase III clinical trial of patients with advanced colorectal cancer after failed first-line treatment, AXEPT Research (Study No. NCT01996306) Objective To investigate the efficacy and tolerance of the modified double-drug combination scheme ( capecitabine&#43; irinotecan, XELIRI for short).

">
  <meta name="twitter:description" content="&nbsp;&nbsp;&nbsp; &nbsp;A team of Chinese, Japanese and Korean researchers led by Professor Xu Ruihua of Sun Yat-sen University&rsquo;s Cancer Hospital conducted a large-scale, multi-center, phase …">
  <meta name="author" content="Ruihua Xu"/>
  <link href='http://cmaorx.github.io/img/favicon.ico' rel='icon' type='image/x-icon'/>
  <meta property="og:image" content="http://cmaorx.github.io/img/p2.png" />
  <meta name="twitter:image" content="http://cmaorx.github.io/img/p2.png" />
  <meta name="twitter:card" content="summary" />
  <meta property="og:url" content="http://cmaorx.github.io/en/post/post1/" />
  <meta property="og:type" content="website" />
  <meta property="og:site_name" content="XU LAB" />

  <meta name="generator" content="Hugo 0.46" />
  <link rel="canonical" href="http://cmaorx.github.io/en/post/post1/" />
  <link rel="alternate" href="http://cmaorx.github.io/index.xml" type="application/rss+xml" title="XU LAB">
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/KaTeX/0.7.1/katex.min.css" integrity="sha384-wITovz90syo1dJWVh32uuETPVEtGigN07tkttEqPv+uR2SE/mbQcG7ATL28aI9H0" crossorigin="anonymous">
  <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css" integrity="sha384-wvfXpqpZZVQGK6TAh5PVlGOfQNHSoD2xbE+QkPxCAFlNEevoEH3Sl0sibVcOQVnN" crossorigin="anonymous">
  <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/css/bootstrap.min.css" integrity="sha384-BVYiiSIFeK1dGmJRAkycuHAHRg32OmUcww7on3RYdg4Va+PmSTsz/K68vbdEjh4u" crossorigin="anonymous">
  <link rel="stylesheet" href="http://cmaorx.github.io/css/main.css" /><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Lora:400,700,400italic,700italic" />
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans:300italic,400italic,600italic,700italic,800italic,400,300,600,700,800" />
  <link rel="stylesheet" href="http://cmaorx.github.io/css/highlight.min.css" /><link rel="stylesheet" href="http://cmaorx.github.io/css/codeblock.css" />



<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/photoswipe/4.1.2/photoswipe.min.css" integrity="sha384-h/L2W9KefUClHWaty3SLE5F/qvc4djlyR4qY3NUV5HGQBBW7stbcfff1+I/vmsHh" crossorigin="anonymous">
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/photoswipe/4.1.2/default-skin/default-skin.min.css" integrity="sha384-iD0dNku6PYSIQLyfTOpB06F2KCZJAKLOThS5HRe8b3ibhdEQ6eKsFf/EeFxdOt5R" crossorigin="anonymous">



<div class="pswp" tabindex="-1" role="dialog" aria-hidden="true">

<div class="pswp__bg"></div>

<div class="pswp__scroll-wrap">
    
    <div class="pswp__container">
      <div class="pswp__item"></div>
      <div class="pswp__item"></div>
      <div class="pswp__item"></div>
    </div>
    
    <div class="pswp__ui pswp__ui--hidden">
    <div class="pswp__top-bar">
      
      <div class="pswp__counter"></div>
      <button class="pswp__button pswp__button--close" title="Close (Esc)"></button>
      <button class="pswp__button pswp__button--share" title="Share"></button>
      <button class="pswp__button pswp__button--fs" title="Toggle fullscreen"></button>
      <button class="pswp__button pswp__button--zoom" title="Zoom in/out"></button>
      
      
      <div class="pswp__preloader">
        <div class="pswp__preloader__icn">
          <div class="pswp__preloader__cut">
            <div class="pswp__preloader__donut"></div>
          </div>
        </div>
      </div>
    </div>
    <div class="pswp__share-modal pswp__share-modal--hidden pswp__single-tap">
      <div class="pswp__share-tooltip"></div>
    </div>
    <button class="pswp__button pswp__button--arrow--left" title="Previous (arrow left)">
    </button>
    <button class="pswp__button pswp__button--arrow--right" title="Next (arrow right)">
    </button>
    <div class="pswp__caption">
      <div class="pswp__caption__center"></div>
    </div>
    </div>
    </div>
</div>

</head>

  <body>
    <nav class="navbar navbar-default navbar-fixed-top navbar-custom">
  <div class="container-fluid">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#main-navbar">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="http://cmaorx.github.io/en/">XU LAB</a>
    </div>

    <div class="collapse navbar-collapse" id="main-navbar">
      <ul class="nav navbar-nav navbar-right">
        
          
            <li>
              <a title="HOME" href="/en/">HOME</a>
            </li>
          
        
          
            <li>
              <a title="PEOPLE" href="/en/page/people/">PEOPLE</a>
            </li>
          
        
          
            <li class="navlinks-container">
              <a class="navlinks-parent" href="javascript:void(0)">PUBLICATIONS</a>
              <div class="navlinks-children">
                
                  <a href="/en/publication/2013article">2013article</a>
                
                  <a href="/en/publication/2014article">2014article</a>
                
                  <a href="/en/publication/2015article">2015article</a>
                
                  <a href="/en/publication/2016article">2016article</a>
                
                  <a href="/en/publication/2017article">2017article</a>
                
                  <a href="/en/publication/2018article">2018article</a>
                
              </div>
            </li>
          
        
          
            <li>
              <a title="About" href="/en/page/about/">About</a>
            </li>
          
        
          
            <li>
              <a title="CONTACT" href="/en/page/contact/">CONTACT</a>
            </li>
          
        
          
            <li>
              <a title="language" href="/en/zh">language</a>
            </li>
          
        
          
            <li>
              <a title="link" href="http://www.sysucc.org.cn">link</a>
            </li>
          
        

        
          
            <li>
              
                
                  <a href="/zh" lang="zh">zh</a>
                
              
                
              
            </li>
          
        

        
      </ul>
    </div>

    <div class="avatar-container">
      <div class="avatar-img-border">
        
          <a title="XU LAB" href="http://cmaorx.github.io/en/">
            <img class="avatar-img" src="http://cmaorx.github.io/img/p2.png" alt="XU LAB" />
          </a>
        
      </div>
    </div>

  </div>
</nav>




    
  
  
  




  

  <header class="header-section ">
    
    <div class="intro-header no-img">
      
      <div class="container">
        <div class="row">
          <div class="col-lg-8 col-lg-offset-2 col-md-10 col-md-offset-1">
            <div class="post-heading">
              <h1>New breakthroughs</h1>
                
                
                  <span class="post-meta">
  
  
  <i class="fa fa-calendar-o"></i>&nbsp;Posted on August 11, 2018
  
  
  &nbsp;|&nbsp;
  <i class="fa fa-clock-o"></i> 2 minutes (918 words)
  
  &nbsp;&bull;&nbsp; Other languages: <a href="http://cmaorx.github.io/zh/post/post1/" lang="zh">zh</a>
</span>


                
            </div>
          </div>
        </div>
      </div>
    </div>
  </header>


    
<div class="container" role="main">
  <div class="row">
    <div class="col-lg-8 col-lg-offset-2 col-md-10 col-md-offset-1">
      <article role="main" class="blog-post">
        <p>&nbsp;&nbsp;&nbsp; &nbsp;A team of Chinese, Japanese and Korean researchers led by Professor Xu Ruihua of Sun Yat-sen University&rsquo;s Cancer Hospital conducted a large-scale, multi-center, phase III clinical trial of patients with advanced colorectal cancer after failed first-line treatment, AXEPT Research (Study No. NCT01996306) Objective To investigate the efficacy and tolerance of the modified double-drug combination scheme ( capecitabine+ irinotecan, XELIRI for short).</p>

<p></p>

<p><a href="link=" title="/img/a1.jpg"><img src=/img/a1.jpg></a></p>

<p>&nbsp;&nbsp;&nbsp; &nbsp; The study is the first to demonstrate that the improved XELIRI is effective and well tolerated, It was recently published online in The Lancet Tumor, the world&rsquo;s top oncological journal, via the Quick Release Channel (just one month from submission to article acceptance) (Latest Impact Factor 33.9).
<a href="link=" title="/img/a2.jpg"><img src=/img/a2.jpg></a>
</br>
   &nbsp;&nbsp;&nbsp; &nbsp;For patients with advanced colorectal cancer, fluorouracil and irinotecan-based dual-drug combination chemotherapy (FOLFIRI) is currently recommended by international guidelines standardizedone of the treatment options.However, the regimen requires a fortnightly, 46-hour infusion, and patients are required to undergo central venous catheterization prior to treatment, the application is extremely inconvenient.
<a href="link=" title="/img/a3.jpg"><img src=/img/a3.jpg></a></p>

<p>&nbsp;&nbsp;&nbsp; &nbsp; Capecitabine is a new type of chemotherapy drug with the same active ingredient as fluorouracil, but is administered orally (every three weeks for a cycle).Compared with the FOLFIRI regimen, the XELIRI regimen of capecitabine combined with irinotecan only needs to be done once every three weeks ~ 3 hours of infusion, and no need for intubation before treatment, the application is more convenient. However, previous clinical studies in Europe and the United States have found that,  The side effects of xeliri in European and American population are very large, and a large number of patients can not tolerate the program and terminate the treatment early.Therefore, the program has not been recommended by the major international guidelines for colorectal cancer.</p>

<p><a href="link=" title="/img/a5.jpg"><img src=/img/a5.jpg></a></p>

<h3 id="a-bold-scientific-assumption">A bold scientific assumption</h3>

<p>Professor Xu Ruihua and Asian scholars have never stopped exploring the clinical problems that European and American scholars have failed to solve.Based on the phase II clinical study conducted by his team, Professor Xu Ruihua prospectively proposed the scientific assumption that appropriately reducing the dose of xeliri program can bring aboutthe reduction of side effects of chemotherapy and the gain of efficacy.</p>

<p>Based on this assumption, Professor Xu Ruihua and Tae Won  Professor Kim ( Kim Tae-wan ), Kei, Cancer Hospital, Aichi Prefecture, Japan  The improved XELIRI scheme ( capecitabine dosage ) was carried out by the international multi-center team of 98 hospitals led by Professor Muro to 800. Mg / m2 Bid,  The amount of irinotecan was reduced to 200  Mg / m2, given every three weeks) in a large phase III axept study.
<a href="link=" title="/img/a4.jpg"><img src=/img/a4.jpg></a></p>

<h3 id="the-new-scheme-is-effective-and-low-toxic">The new scheme is effective and low toxic.</h3>

<p>&nbsp;&nbsp;&nbsp; &nbsp; The axept study took more than three years (December 2013)~ june 2017), a total of 650 patients with advanced colorectal cancer who had failed first-line chemotherapy were enrolled.Nearly one third of the Chinese subjects were enrolled in the Cancer Center of Sun Yat-sen University. The results showed that patients receiving the improved XELIRI regimen had an average survival of 17 months, which was not inferior to or even exceeded the risk of receiving a FOLFIRI regimen the mean survival time was 15 months.</p>

<p>Compared with FOLFIRI regimen, the incidence of adverse reactions in the modified xeliri regimen was significantly reduced (from 72% to 54%).The incidence of cytopenia was reduced by more than half ( from 45 % to 20 % ).</p>

<h3 id="the-new-scheme-has-become-the-new-standard-for-the-chemotherapy-of-bowel-cancer">The new scheme has become the new standard for the chemotherapy of bowel cancer</h3>

<p>&nbsp;&nbsp;&nbsp; &nbsp; As the survival time of patients with advanced colorectal cancer continues to extend, how to improve the quality of life of these patients is also increasingly attention.The axept study confirmed for the first time that the improved xeliri regimen was as effective and better tolerated than the international standard FOLFIRI regimen.The application is more convenient, and the quality of life of the patients is improved while ensuring the therapeutic effect. In addition, the improved xeliri regimen was similar to FOLFIRI regimen in terms of treatment cost, but the time of returning to hospital was extended from once every two weeks to once every three weeks.And the time of each hospitalization was shortened from 3 days to 1 day, which greatly improved the compliance of patients and also reduced the cost of transportation.</p>

<p><a href="link=" title="/img/a6.jpg"><img src=/img/a6.jpg></a></p>

<p>&nbsp;&nbsp;&nbsp; &nbsp;  The AXEPT study was highly recognized by international colleagues : Timothy, head of the Australian Clinical Research Cooperation Group, in a review of experts published in The Lancet Oncology  Professor price said: &ldquo;Chemotherapy with oral chemotherapy drugs can simplify treatment.The axept study is the first international multicenter, randomized, phase III clinical trial comparing the modified xeliri regimen with the FOLFIRI regimen.Based on the results of the study, the modified XELIRI scheme is expected to replace the FOLFIRI program as a new type of colorectal cancer in the world, especially in the advanced stage of colorectal cancer standard chemotherapy regimens, modified liquidity, and some clinical practice. In addition, shortly after the results of the study were published, the European Society of Oncology&rsquo;s Guide to Pan-Asian Colorectal Cancer has been adopted.</p>

<p>&nbsp;&nbsp;&nbsp; &nbsp;   During the axept research period, the main researchers of China, Japan and South Korea conducted a total of nine academic committee meetings, through meetings to discuss the implementation of the project repeatedly encountered problemsthe success of this study has undoubtedly provided valuable experience for the development of clinical research in China, and demonstrated that the clinical research in the field of colorectal cancer in China has been successful.And run the first class level in the world.
</br>
</br>
</br></p>

<hr />

<p><font size="2" color="宋体">
Click on the &ldquo;reading&rdquo; view the original research:<a href="https://www.thelancet.com/journals/lanonc/onlineFirst">Reading</a></br>
Copy from:wechant<a href="https://mp.weixin.qq.com/s/AULQl-LtRaCYxd_pBM0B8A">SYSUCC1964</a>
</font></p>

        
          <div class="blog-tags">
            
              <a href="http://cmaorx.github.io/en/tags/colorectal-cancer/">colorectal cancer</a>&nbsp;
            
          </div>
        

        
            <hr/>
            <section id="social-share">
              <ul class="list-inline footer-links">
                


<li>
    <a href="//twitter.com/share?url=http%3a%2f%2fcmaorx.github.io%2fen%2fpost%2fpost1%2f&amp;text=New%20breakthroughs&amp;via="
       target="_blank" alt="" title="Share on Twitter">
        <span class="fa-stack fa-lg">
                <i class="fa fa-circle fa-stack-2x"></i>
                <i class="fa fa-twitter fa-stack-1x fa-inverse"></i>
              </span>
    </a>
</li>


<li>
    <a href="//plus.google.com/share?url=http%3a%2f%2fcmaorx.github.io%2fen%2fpost%2fpost1%2f" target="_blank" title="Share on Google Plus">
         <span class="fa-stack fa-lg">
                <i class="fa fa-circle fa-stack-2x"></i>
                <i class="fa fa-google-plus fa-stack-1x fa-inverse"></i>
              </span>
    </a>
</li>


<li>
    <a href="//www.facebook.com/sharer/sharer.php?u=http%3a%2f%2fcmaorx.github.io%2fen%2fpost%2fpost1%2f" target="_blank" title="Share on Facebook">
        <span class="fa-stack fa-lg">
                <i class="fa fa-circle fa-stack-2x"></i>
                <i class="fa fa-facebook fa-stack-1x fa-inverse"></i>
              </span>
    </a>
</li>


<li>
    <a href="//reddit.com/submit?url=http%3a%2f%2fcmaorx.github.io%2fen%2fpost%2fpost1%2f&amp;title=New%20breakthroughs" target="_blank" title="Share on Reddit">
         <span class="fa-stack fa-lg">
                <i class="fa fa-circle fa-stack-2x"></i>
                <i class="fa fa-reddit fa-stack-1x fa-inverse"></i>
              </span>
    </a>
</li>


<li>
    <a href="//www.linkedin.com/shareArticle?url=http%3a%2f%2fcmaorx.github.io%2fen%2fpost%2fpost1%2f&amp;title=New%20breakthroughs" target="_blank"
       title="Share on LinkedIn">
         <span class="fa-stack fa-lg">
                <i class="fa fa-circle fa-stack-2x"></i>
                <i class="fa fa-linkedin fa-stack-1x fa-inverse"></i>
              </span>
    </a>
</li>


<li>
    <a href="//www.stumbleupon.com/submit?url=http%3a%2f%2fcmaorx.github.io%2fen%2fpost%2fpost1%2f&amp;title=New%20breakthroughs" target="_blank"
       title="Share on StumbleUpon">
        <span class="fa-stack fa-lg">
                <i class="fa fa-circle fa-stack-2x"></i>
                <i class="fa fa-stumbleupon fa-stack-1x fa-inverse"></i>
              </span>
    </a>
</li>


<li>
    <a href="//www.pinterest.com/pin/create/button/?url=http%3a%2f%2fcmaorx.github.io%2fen%2fpost%2fpost1%2f&amp;description=New%20breakthroughs" target="_blank"
       title="Share on Pinterest">
         <span class="fa-stack fa-lg">
                <i class="fa fa-circle fa-stack-2x"></i>
                <i class="fa fa-pinterest fa-stack-1x fa-inverse"></i>
              </span>
    </a>
</li>

              </ul>
            </section>
        
      </article>

      
        <ul class="pager blog-pager">
          
          
            <li class="next">
              <a href="http://cmaorx.github.io/en/post/post2/" data-toggle="tooltip" data-placement="top" title="The second term of “Famous National Doctor”.">Next Post &rarr;</a>
            </li>
          
        </ul>
      


      
        
        
      

    </div>
  </div>
</div>

    <footer>
  <div class="container">
    <div class="row">
      <div class="col-lg-8 col-lg-offset-2 col-md-10 col-md-offset-1">
        <ul class="list-inline text-center footer-links">
          
          
          <li>
            
            <a href="http://cmaorx.github.io/index.xml" title="RSS">
            
              <span class="fa-stack fa-lg">
                <i class="fa fa-circle fa-stack-2x"></i>
                <i class="fa fa-rss fa-stack-1x fa-inverse"></i>
              </span>
            </a>
          </li>
          
        </ul>
        <p class="credits copyright text-muted">
          
            
              Ruihua Xu
            
          

          &nbsp;&bull;&nbsp;
          2018

          
            &nbsp;&bull;&nbsp;
            <a href="http://cmaorx.github.io/en/">XU LAB</a>
          
        </p>
        
        <p class="credits theme-by text-muted">
          <a href="http://gohugo.io">Hugo v0.46</a> powered &nbsp;&bull;&nbsp; Theme by <a href="http://deanattali.com/beautiful-jekyll/">Beautiful Jekyll</a> adapted to <a href="https://github.com/halogenica/beautifulhugo">Beautiful Hugo</a>
          
        </p>
      </div>
    </div>
  </div>
</footer>

<script src="https://cdnjs.cloudflare.com/ajax/libs/KaTeX/0.7.1/katex.min.js" integrity="sha384-/y1Nn9+QQAipbNQWU65krzJralCnuOasHncUFXGkdwntGeSvQicrYkiUBwsgUqc1" crossorigin="anonymous"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/KaTeX/0.7.1/contrib/auto-render.min.js" integrity="sha384-dq1/gEHSxPZQ7DdrM82ID4YVol9BYyU7GbWlIwnwyPzotpoc57wDw/guX8EaYGPx" crossorigin="anonymous"></script>
<script src="https://code.jquery.com/jquery-1.12.4.min.js" integrity="sha256-ZosEbRLbNQzLpnKIkEdrPv7lOy9C27hHQ+Xp8a4MxAQ=" crossorigin="anonymous"></script>
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/js/bootstrap.min.js" integrity="sha384-Tc5IQib027qvyjSMfHjOMaLkfuWVxZxUPnCJA7l2mCWNIpG9mGCD8wGNIcPD7Txa" crossorigin="anonymous"></script>
<script src="http://cmaorx.github.io/js/main.js"></script>
<script src="http://cmaorx.github.io/js/highlight.min.js"></script>
<script> hljs.initHighlightingOnLoad(); </script>
<script> $(document).ready(function() {$("pre.chroma").css("padding","0");}); </script><script> renderMathInElement(document.body); </script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/photoswipe/4.1.2/photoswipe.min.js" integrity="sha384-QELNnmcmU8IR9ZAykt67vGr9/rZJdHbiWi64V88fCPaOohUlHCqUD/unNN0BXSqy" crossorigin="anonymous"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/photoswipe/4.1.2/photoswipe-ui-default.min.js" integrity="sha384-m67o7SkQ1ALzKZIFh4CiTA8tmadaujiTa9Vu+nqPSwDOqHrDmxLezTdFln8077+q" crossorigin="anonymous"></script>
<script src="http://cmaorx.github.io/js/load-photoswipe.js"></script>






  </body>
</html>

